- Home
- HRL vs TEVA Comparison
HRL vs TEVA Comparison
Compare HRL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRL
- TEVA
- Stock Information
- Founded
- HRL 1891
- TEVA 1901
- Country
- HRL United States
- TEVA Israel
- Employees
- HRL N/A
- TEVA N/A
- Industry
- HRL Meat/Poultry/Fish
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- HRL Consumer Staples
- TEVA Health Care
- Exchange
- HRL Nasdaq
- TEVA Nasdaq
- Market Cap
- HRL 17.8B
- TEVA 19.2B
- IPO Year
- HRL N/A
- TEVA N/A
- Fundamental
- Price
- HRL $31.90
- TEVA $21.20
- Analyst Decision
- HRL Hold
- TEVA Buy
- Analyst Count
- HRL 6
- TEVA 7
- Target Price
- HRL $32.33
- TEVA $21.00
- AVG Volume (30 Days)
- HRL 2.6M
- TEVA 11.0M
- Earning Date
- HRL 12-04-2024
- TEVA 01-29-2025
- Dividend Yield
- HRL 3.55%
- TEVA N/A
- EPS Growth
- HRL 1.29
- TEVA N/A
- EPS
- HRL 1.47
- TEVA N/A
- Revenue
- HRL $11,920,797,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- HRL $3.77
- TEVA $4.70
- Revenue Next Year
- HRL $2.44
- TEVA $4.47
- P/E Ratio
- HRL $21.83
- TEVA N/A
- Revenue Growth
- HRL N/A
- TEVA 9.81
- 52 Week Low
- HRL $28.51
- TEVA $10.34
- 52 Week High
- HRL $36.86
- TEVA $21.98
- Technical
- Relative Strength Index (RSI)
- HRL 49.53
- TEVA 75.06
- Support Level
- HRL $32.38
- TEVA $16.25
- Resistance Level
- HRL $33.12
- TEVA $17.72
- Average True Range (ATR)
- HRL 0.73
- TEVA 0.78
- MACD
- HRL -0.07
- TEVA 0.40
- Stochastic Oscillator
- HRL 35.64
- TEVA 86.39
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (64% of fiscal 2023 sales), US food service (30%), and international (6%). By product, 70% of fiscal 2023 sales were from perishable food and 30% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.